de Llano, Luis Pérez
Castro-Añón, Olalla
Castro-Cabana, Laura
Méndez Marote, Lidia
Golpe, Rafael http://orcid.org/0000-0002-3759-5322
Article History
Received: 26 May 2020
Revised: 9 August 2020
Accepted: 19 August 2020
First Online: 26 August 2020
Compliance with ethical standards
:
: Luis Perez de Llano declares to have received grants and/or fees for consultancy or speeches from Novartis, Astra-Zeneca, GSK, Teva, Boehringer-Ingelheim, Chiesi, Sanofi, Menarini, Mundipharma, and Esteve. Rafael Golpe declares that he has received speaking or advisory fees, or economic aid to attend congresses from Astra-Zeneca, GSK, Novartis, Chiesi, Mundipharma, Menarini, TEVA, Grifols, Ferrer, Boehringer-Ingelheim, Rovi, and Gebro. The rest of the authors declare that they have no conflict of interests.
: The study was approved by the Galician Ethics Committee (Reg. No. 2017/079).
: Not applicable.